Virginia García-Reglero

Suggest Changes
Learn More
PURPOSE Advanced non-small cell lung cancer (NSCLC) is a common and lethal malignancy that has rarely benefited from chemotherapy. Erlotinib is highly effective in NSCLC patients selected by clinical(More)
e17527 Background: Neoadjuvant concurrent chemoradiotherapy (CTRT) is a promising therapeutic approach for locally advanced non-small cell lung cancer (NSCLL), but the optimal regimen of drugs for(More)
  • 1